Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women

Publish Year : 2016
Publisher : New England Journal of Medicine
Author Name : Nel A., van Niekerk N., Kapiga S., Bekker L.G., Gama C., Gill K., Kamali A., Kotze P., Louw C., Mabude Z., Miti N., Kusemererwa S., Tempelman H., Carstens H., Devlin B., Isaacs M., Malherbe M., Mans W., Nuttall J., Russell M., Ntshele S., Smit M., Solai L., Spence P., Steytler J., Windle K., Borremans M., Resseler S., Van Roey J., Parys W., Vangeneugden T., Van Baelen B., and Rosenberg Z.
Link : Click here

Description :

This article evaluates the safety and efficacy of a vaginal ring containing dapivirine for the prevention of HIV infection in nearly 2,000 women of reproductive age from South Africa and Uganda. The study was a randomized, double-blind, placebo-controlled trial and it found that the dapivirine ring was not associated with any safety concerns and was associated with a lower rate of HIV-1 infection than the placebo rate.

Recent Resources

Self-Esteem and Hope among HIV Positive Adolescents

The aim of the present study was to assess the level of self-esteem and Hope among HIV positive...

Manifestations of Gender Inequality and Its Influence on Health Service Use Among Female Injecting Drug Users - A Study in Champai, Mizoram

Gender inequalities affect women’s access to and experience of HIV/AIDS programmes and services. The...

Spotlight — HIV–related discrimination against women and girls — Zero Discrimination Day 1 March 2020

A cross the world, gender inequality, violence, poverty and insecurity continue to stoke excessive...

View More